Annual Report

Overview

The report describes Strides Pharma Science Limited's FY 2019-20 performance across regulated and emerging pharmaceutical markets, with reported consolidated revenue of ₹27,637 Million. It highlights the company's COVID-19 response, including employee continuity measures, meals for disadvantaged people, ventilators and protective supplies. The report also details community programs in health, education and employability, alongside workforce initiatives covering safety, learning and non-discrimination.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Publication date: 20 May 2020
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services